Drug recall
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister…
FDA recall event 63031 · Class II · Caraco Pharmaceutical Laboratories Ltd.
Key facts
| Event ID | 63031 |
|---|---|
| Recall numbers | D-003-2013 |
| Recalling firm | Caraco Pharmaceutical Laboratories Ltd. |
| Product type | Drugs |
| Products | Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Crystallization: Presence of crystals of Nimodipine within the capsule solution. |
| Initiation date | Aug 21, 2012 |
| Report date | Oct 10, 2012 |
| Termination date | Nov 19, 2013 |
| City | Cranbury |
| State | NJ |
| Country | United States |
| FEI number | 3005551493 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: